CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $70,000 | -43.1% | 29,992 | -30.7% | 0.00% | -100.0% |
Q4 2017 | $123,000 | +324.1% | 43,253 | +325.0% | 0.00% | – |
Q3 2017 | $29,000 | -31.0% | 10,176 | -2.7% | 0.00% | – |
Q3 2016 | $42,000 | -30.0% | 10,459 | -23.1% | 0.00% | – |
Q2 2016 | $60,000 | +27.7% | 13,600 | +10.4% | 0.00% | – |
Q1 2016 | $47,000 | -67.1% | 12,323 | +34.8% | 0.00% | -100.0% |
Q4 2015 | $143,000 | +12.6% | 9,143 | -24.3% | 0.00% | 0.0% |
Q3 2015 | $127,000 | +35.1% | 12,071 | +225.5% | 0.00% | 0.0% |
Q2 2015 | $94,000 | +14.6% | 3,709 | +26.4% | 0.00% | 0.0% |
Q1 2015 | $82,000 | +67.3% | 2,935 | +8.4% | 0.00% | – |
Q4 2014 | $49,000 | +16.7% | 2,708 | -16.3% | 0.00% | – |
Q3 2014 | $42,000 | -19.2% | 3,235 | +2.4% | 0.00% | – |
Q2 2014 | $52,000 | -7.1% | 3,160 | 0.0% | 0.00% | -100.0% |
Q1 2014 | $56,000 | -30.0% | 3,160 | -3.9% | 0.00% | 0.0% |
Q4 2013 | $80,000 | -78.2% | 3,287 | -68.2% | 0.00% | -66.7% |
Q3 2013 | $367,000 | +326.7% | 10,347 | +88.5% | 0.00% | +200.0% |
Q2 2013 | $86,000 | – | 5,489 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,006 | $24,302,000 | 100.00% |
TSP Capital Management Group, LLC | 886,398 | $3,138,000 | 1.60% |
Marcus Capital, LLC | 109,950 | $389,000 | 0.42% |
RTW INVESTMENTS, LP | 239,662 | $848,000 | 0.32% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 6,195,855 | $21,933,000 | 0.31% |
Benchmark Capital Advisors | 66,800 | $236,000 | 0.20% |
Bellevue Group AG | 160,000 | $566,000 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 632,944 | $2,241,000 | 0.09% |
PDT Partners, LLC | 369,300 | $1,307,000 | 0.09% |
Vident Investment Advisory, LLC | 196,715 | $696,000 | 0.08% |